Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
For decades, the FDA has treated injectable peptides, like insulin, as drugs
This formulation combines several well-characterised compounds commonly referenced in dermatological and cosmetic research environments, creating a blend of interest for experimental work involving connective tissue, cosmetic science, and broader regenerative research models
The Phase 2 clinical data makes the case numerically
Should you want to return your product, we hope your customer service experience is more expedient than ours was
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
US$ 20.95
US$ 27.58
US$ 29.90
US$ 20.10
US$ 22.99
US$ 21.29
